We are live on ! Find out more
NYMX

Nymox Pharmaceutical Corp
NYMX

Delisted

NYMX was delisted on the 6th of July, 2023.

Back to rankings

59 hedge funds and large institutions have $13.3M invested in Nymox Pharmaceutical Corp in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 21 increasing their positions, 13 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

246% more call options, than puts

Call options by funds: $45K | Put options by funds: $13K

62% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 13

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

2% more funds holding

Funds holding: 58 → 59 (+1)

6% less capital invested

Capital invested by funds: $14.2M → $13.3M (-$924K)

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
21
Reduced
13
Closed
3
Calls
$45K
Puts
$13K
Net Calls
+$32K
Net Calls Change
+$89K

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$505K
2
BlackRock
BlackRock
New York
+$167K
3
Bank of America
Bank of America
North Carolina
+$133K
4
State Street
State Street
Massachusetts
+$133K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$66.6K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$168K
2
Morgan Stanley
Morgan Stanley
New York
-$94.8K
3
Northern Trust
Northern Trust
Illinois
-$76.2K
4
FDCDDQ
Federation des caisses Desjardins du Quebec
Quebec, Canada
-$65.9K
5
TRCT
Tower Research Capital (TRC)
New York
-$54.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
GAM
26
Geier Asset Management
Maryland
$72K – – –
PAG
27
Private Advisor Group
New Jersey
$69K – – –
RhumbLine Advisers
28
RhumbLine Advisers
Massachusetts
$68K +$264 +100 +0.3%
Deutsche Bank
29
Deutsche Bank
Germany
$67K -$6.77K -2,568 -8%
Invesco
30
Invesco
Georgia
$63K +$3.17K +1,201 +4%
Goldman Sachs
31
Goldman Sachs
New York
$63K +$7.98K +3,028 +12%
BAS
32
Brown Advisory Securities
Maryland
$62K – – –
GG
33
Gofen & Glossberg
Illinois
$56K – – –
WCWM
34
Willow Creek Wealth Management
California
$54K – – –
VOYA Investment Management
35
VOYA Investment Management
Georgia
$48K – – –
Brown Advisory
36
Brown Advisory
Maryland
$42K – – –
UBS Group
37
UBS Group
Switzerland
$42K +$20K +7,579 +66%
Creative Planning
38
Creative Planning
Kansas
$40K – – –
Credit Agricole
39
Credit Agricole
France
$40K – – –
Millennium Management
40
Millennium Management
New York
$37K +$44K +16,712 New
VF
41
Virtu Financial
New York
$28K +$32.9K +12,488 New
KAS
42
Kestra Advisory Services
Texas
$26K – – –
CAM
43
Cubic Asset Management
Massachusetts
$26K +$659 +250 +2%
ProShare Advisors
44
ProShare Advisors
Maryland
$25K +$29.8K +11,299 New
BNP Paribas Financial Markets
45
BNP Paribas Financial Markets
France
$13.6K -$669 -254 -4%
Simplex Trading
46
Simplex Trading
Illinois
$12K +$11.9K +4,531 +471%
TRCT
47
Tower Research Capital (TRC)
New York
$11K -$54.3K -20,603 -80%
Legal & General Group
48
Legal & General Group
United Kingdom
$11K – – –
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$11K +$10.5K +3,979 +398%
AIP
50
Ameritas Investment Partners
Nebraska
$8K – – –
1
2
3

NYMX Hedge Fund Activity: Q1 2021 in Review

59 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Nymox Pharmaceutical Corp (NYMX) for Q1 2021, worth a combined $13.3M — down 6.5% from $14.2M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new NYMX positions and 3 closed out — a net gain of 1 holder — while 21 added to existing stakes and 13 trimmed.

The largest buyer was Wells Fargo, adding an estimated $505K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $168K sold.

  • 59 institutional investors held Nymox Pharmaceutical Corp (NYMX) as of Q1 2021, up from 58 in Q4 2020.
  • Funds reported $13.3M of Nymox Pharmaceutical Corp stock for Q1 2021, down 6.5% quarter-over-quarter.
  • 4 funds opened new Nymox Pharmaceutical Corp positions in Q1 2021 and 3 closed out, a net change of +1 holder.
  • The largest Nymox Pharmaceutical Corp buyer in Q1 2021 was Wells Fargo, an estimated $505K added.
  • The largest Nymox Pharmaceutical Corp seller in Q1 2021 was Renaissance Technologies, an estimated $168K sold.

Based on aggregated 13F filings for Q1 2021.